Diversified Healthcare Trust - 6.25% NT REDEEM 01/02/2046 USD 25 EBIT

The latest EBIT for DHCNL is $-100M as of March 2026. That compares with $-390M in the prior-year period — up 73.6% year over year. That is below the Finance sector average of $300B. Investors often review this figure alongside Diversified Healthcare Trust - 6.25% NT REDEEM 01/02/2046 USD 25's historical trend and sector peers before judging valuation or financial health.

Over the past year, DHCNL's EBIT moved from $-390M to $-100M — a 73.6% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Diversified Healthcare Trust - 6.25% NT REDEEM 01/02/2046 USD 25's operating scale or balance-sheet position.

Against Finance companies, DHCNL currently prints $-100M for EBIT, while the sector average sits near $300B. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at Diversified Healthcare Trust - 6.25% NT REDEEM 01/02/2046 USD 25's growth, margins, and balance sheet.

A EBIT figure of $-100M for DHCNL is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Finance average is about $300B. Explore the charts below for those layers of context.

After noting DHCNL's EBIT ($-100M), review year-over-year change from $-390M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.